Zemaira Kit
Product Images NDC 0053-7203

15 FDA label images from Csl Behring Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Zemaira (NDC 0053-7203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Csl Behring Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig. 1 (Zemaira 01)

Fig. 1 (Zemaira 01)
An instructional illustration showing a kit setup for ZEMAIRA, Alpha-1-Proteinase Inhibitor Human plasma derivative. It includes a vial labeled 'PRODUCT,' a vial labeled 'WATER,' and an infusion device with a drip chamber and tubing, indicating preparation or administration steps.*
FDA Label Image

Fig. 2 (Zemaira 02)

Fig. 2 (Zemaira 02)
An instructional illustration showing the placement of a cup upside down over a vial labeled 'WATER'. An arrow indicates the direction to position the cup firmly onto the vial. The image is likely part of usage directions for the ZEMAIRA kit containing Alpha-1-Proteinase Inhibitor Human, manufactured by CSL Behring LLC.*
FDA Label Image

Fig. 3 (Zemaira 03)

Fig. 3 (Zemaira 03)
Illustration showing how to remove a cap from a vial labeled 'WATER.' The cap is shown above the vial with an upward arrow indicating it should be pulled off. This is likely part of instructions for preparing the ZEMAIRA kit containing alpha-1-proteinase inhibitor human.*
FDA Label Image

Fig. 4 (Zemaira 04)

Fig. 4 (Zemaira 04)
An instructional diagram showing the assembly of a ZEMAIRA kit for administration. It depicts a water vial connected to a filter device, with an arrow indicating the water is to be pushed through the filter into a product vial labeled 'PRODUCT.' This illustrates the reconstitution process of the plasma derivative kit.*
FDA Label Image

Fig. 5 (Zemaira 05)

Fig. 5 (Zemaira 05)
An instructional illustration showing two hands preparing a product vial labeled 'PRODUCT.' One hand holds the vial while the other hand removes a cap from a dropper or connector, indicating a step in medication preparation or administration.*
FDA Label Image

Fig. 6 (Zemaira 06)

Fig. 6 (Zemaira 06)
Illustration showing a vial labeled 'PRODUCT' with a cap, indicating a rotational arrow around the vial's base. This suggests instructions for handling or mixing the product contained in the vial.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
Packaging label for Zemaira Alpha1-Proteinase Inhibitor (Human) plasma derivative kit. The label indicates a single dose vial with diluent in the 1000 mg range strength. The product is for intravenous administration only and is labeled for prescription use only. It is manufactured by CSL Behring LLC. The label includes storage instructions, NDC 0053-7201-02, and branding elements in blue and red on a white background.*
FDA Label Image

Principal Display Panel (1000 mg Vial Label)

Principal Display Panel (1000 mg Vial Label)
Packaging label for ZEMAIRA, an Alpha-1-Proteinase Inhibitor (Human) plasma derivative kit by CSL Behring LLC. The label indicates a 4000 mg range dosage for one single dose vial with diluent. The design includes the proprietary and generic names, storage instructions, manufacturer details, and the NDC number 0053-7202-02.*
FDA Label Image

Principal Display Panel (20 mL Vial Label)

Principal Display Panel (20 mL Vial Label)
Packaging label for Zemaira 5000 mg range Alpha1-Proteinase Inhibitor (Human) Kit by CSL Behring LLC. The label states the product is a plasma derivative for intravenous administration only, including one single dose vial with diluent. The label displays the proprietary name Zemaira, active ingredient, dosage form Kit, and manufacturer information.*
FDA Label Image

Principal Display Panel (4000 mg Range)

Principal Display Panel (4000 mg Range)
Packaging label for ZEMAIRA, a kit containing Alpha1-Proteinase Inhibitor Human plasma derivative. The label highlights a 4000 mg range and indicates a single-dose vial with diluent for intravenous administration. Manufactured by CSL Behring LLC, the label includes handling and storage details, user instructions, and barcode information.*
FDA Label Image

Principal Display Panel (4000 mg Vial Label)

Principal Display Panel (4000 mg Vial Label)
ZEMAIRA Alpha1-Proteinase Inhibitor (Human) kit packaging label by CSL Behring LLC. The label includes storage instructions up to 25°C (77°F), and specifies IV use only. It features dosage and administration notes, lot and expiration date sections, and manufacturer details from Kankakee, IL.*
FDA Label Image

Principal Display Panel (76 mL Vial Label)

Principal Display Panel (76 mL Vial Label)
Packaging label for Sterile Water for Injection, USP, 76 mL, manufactured by CSL Behring LLC, Kankakee, IL. The label cautions that the solution is not suitable for intravascular injection unless made approximately isotonic by adding a suitable solute, and states that it contains no preservative. Includes lot and expiration date placeholders.*
FDA Label Image

Principal Display Panel (5000 mg Range)

Principal Display Panel (5000 mg Range)
Packaging label for ZEMAIRA Alpha1-Proteinase Inhibitor (Human) 5000 mg range KIT by CSL Behring LLC. The label states it contains one single-dose vial with diluent for intravenous administration only, including storage instructions and manufacturer details. The design includes the product name, strength, and NDC 0053-7203-02, with branding elements in blue and red.*
FDA Label Image

Principal Display Panel (5000 mg Vial Label)

Principal Display Panel (5000 mg Vial Label)
Packaging label for ZEMAIRA, a plasma derivative kit containing Alpha1-Proteinase Inhibitor (Human). The label includes storage instructions to keep up to 25°C (77°F), indicates IV use only, and lists CSL Behring LLC as the manufacturer in Kankakee, IL. It also notes no preservatives and instructions for reconstitution within three hours.*
FDA Label Image

Principal Display Panel (95 mL Vial Label)

Principal Display Panel (95 mL Vial Label)
Label for Sterile Water for Injection, USP, 95 mL manufactured by CSL Behring LLC, Kankakee, IL. The label cautions that the solution is not suitable for intravascular injection without making it approximately isotonic by adding a suitable solute. It contains no preservative and is for Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.